Carcinoma, Transitional Cell
"Carcinoma, Transitional Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Descriptor ID |
D002295
|
| MeSH Number(s) |
C04.557.470.200.430
|
| Concept/Terms |
Carcinoma, Transitional Cell- Carcinoma, Transitional Cell
- Carcinomas, Transitional Cell
- Cell Carcinoma, Transitional
- Cell Carcinomas, Transitional
- Transitional Cell Carcinoma
- Transitional Cell Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Transitional Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Transitional Cell".
This graph shows the total number of publications written about "Carcinoma, Transitional Cell" by people in this website by year, and whether "Carcinoma, Transitional Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 10 | 1 | 11 |
| 1995 | 6 | 1 | 7 |
| 1996 | 9 | 1 | 10 |
| 1997 | 10 | 0 | 10 |
| 1998 | 8 | 1 | 9 |
| 1999 | 10 | 3 | 13 |
| 2000 | 10 | 1 | 11 |
| 2001 | 18 | 1 | 19 |
| 2002 | 13 | 0 | 13 |
| 2003 | 21 | 6 | 27 |
| 2004 | 11 | 3 | 14 |
| 2005 | 9 | 3 | 12 |
| 2006 | 28 | 4 | 32 |
| 2007 | 22 | 2 | 24 |
| 2008 | 20 | 4 | 24 |
| 2009 | 22 | 1 | 23 |
| 2010 | 29 | 2 | 31 |
| 2011 | 15 | 2 | 17 |
| 2012 | 17 | 1 | 18 |
| 2013 | 13 | 2 | 15 |
| 2014 | 19 | 0 | 19 |
| 2015 | 15 | 2 | 17 |
| 2016 | 17 | 1 | 18 |
| 2017 | 18 | 0 | 18 |
| 2018 | 17 | 0 | 17 |
| 2019 | 22 | 0 | 22 |
| 2020 | 17 | 1 | 18 |
| 2021 | 28 | 0 | 28 |
| 2022 | 25 | 0 | 25 |
| 2023 | 24 | 0 | 24 |
| 2024 | 5 | 6 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Transitional Cell" by people in Profiles.
-
Diagnostic accuracy of upper tract urothelial carcinoma using biopsy, urinary cytology, and nephroureterectomy specimens: A tertiary cancer center experience. Am J Clin Pathol. 2024 Nov 04; 162(5):492-499.
-
Novel therapeutic regimens in previously untreated metastatic urothelial carcinoma: A systematic review and bayesian network meta-analysis. Urol Oncol. 2024 Nov; 42(11):361-369.
-
Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience. Urol Oncol. 2024 Sep; 42(9):291.e13-291.e25.
-
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations. JNCI Cancer Spectr. 2024 Apr 30; 8(3).
-
Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases. Hum Pathol. 2024 06; 148:1-6.
-
Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel. Clin Genitourin Cancer. 2024 Aug; 22(4):102091.
-
Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma. J Urol. 2024 Jun; 211(6):784-793.
-
Prognostic Value of Fibroblast Growth Factor Receptor Genetic Alterations in Metastatic Urothelial Carcinoma. Clin Genitourin Cancer. 2024 Jun; 22(3):102054.
-
Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat Rev Urol. 2024 07; 21(7):391-405.
-
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2. Mod Pathol. 2024 Mar; 37(3):100424.